FDA Approves PET Imaging Agent Amyvid

April 11, 2012

The Food and Drug Administration (FDA) has approved the PET imaging agent Amyvid, developed by Eli Lily and Co. and Avid Radiopharmaceuticals.  The agent is used to detect beta-amyloid plaques which are associated with Alzheimer’s disease.  

To learn more: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm299678.htm